Trials / Sponsors / CanBas Co. Ltd.
CanBas Co. Ltd.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer Pancreatic Cancer Stage IV | Phase 2 | 2021-12-18 |
| Completed | CBP501, Cisplatin and Nivolumab in Advanced Refractory Tumors Advanced Solid Tumors | Phase 1 | 2017-10-25 |
| Completed | Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC) Metastatic Non-squamous Non Small Cell Lung Cancer | Phase 2 | 2009-04-01 |
| Completed | Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) Malignant Pleural Mesothelioma, Solid Tumors | Phase 1 / Phase 2 | 2008-05-01 |
| Completed | Phase I Study of CBP501 and Cisplatin in Patients With Advanced Refractory Solid Tumors Cancer, Solid Tumors | Phase 1 | 2006-11-01 |